Vontobel Holding’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-9,061
Closed -$212K – 1112
2023
Q1
$212K Sell
9,061
-551
-6% -$15.7K ﹤0.01% 969
2022
Q4
$245K Sell
9,612
-2,303
-19% -$105K ﹤0.01% 940
2022
Q3
$641K Sell
11,915
-948
-7% -$48.7K 0.01% 645
2022
Q2
$541K Sell
12,863
-3,685
-22% -$183K 0.01% 698
2022
Q1
$1.11M Buy
16,548
+2,797
+20% +$191K 0.01% 589
2021
Q4
$1.38M Buy
13,751
+2,142
+18% +$222K 0.01% 550
2021
Q3
$1.45M Buy
11,609
+997
+9% +$118K 0.01% 525
2021
Q2
$1.36M Buy
10,612
+5,091
+92% +$685K 0.01% 523
2021
Q1
$843K Buy
5,521
+33
+0.6% +$4.99K 0.01% 561
2020
Q4
$889K Buy
+5,488
New +$631K 0.01% 546

Other funds holding GH

Vontobel Holding's GH Position: Q2 2023 in Review

Vontobel Holding sold out of Guardant Health (GH) in Q2 2023, closing a stake of 9,061 shares — an estimated $212K sold.

Vontobel Holding first reported a position in GH in Q4 2020 and held it in 10 quarters. The position peaked at $1.45M in Q3 2021. 299 funds tracked by Wall St. Rank hold GH as of Q2 2023.

  • Vontobel Holding reported no remaining Guardant Health position as of Q2 2023 after selling out during the quarter.
  • Vontobel Holding sold 9,061 Guardant Health shares in Q2 2023, an estimated $212K.
  • Vontobel Holding first reported a position in Guardant Health in Q4 2020 and held it in 10 quarters.
  • Vontobel Holding's Guardant Health position peaked at $1.45M in Q3 2021.
  • 299 funds tracked by Wall St. Rank held Guardant Health as of Q2 2023.

Based on Vontobel Holding's 13F filing for Q2 2023, filed 24 Jul 2023.